![IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors](https://www.mdpi.com/ijms/ijms-23-08069/article_deploy/html/images/ijms-23-08069-g004.png)
IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors
![Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia | Nature Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia | Nature](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnature09884/MediaObjects/41586_2011_Article_BFnature09884_Fig2_HTML.jpg)
Duplications of the neuropeptide receptor gene VIPR2 confer significant risk for schizophrenia | Nature
![Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma | Nature Communications Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-34242-4/MediaObjects/41467_2022_34242_Fig1_HTML.png)
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma | Nature Communications
![IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors](https://pub.mdpi-res.com/ijms/ijms-23-08069/article_deploy/html/images/ijms-23-08069-g003.png?1658482745)
IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors
![Frontiers | A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease Frontiers | A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease](https://www.frontiersin.org/files/Articles/482521/fncel-13-00421-HTML/image_m/fncel-13-00421-g003.jpg)
Frontiers | A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease
![VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair - Waschek - 2013 - British Journal of Pharmacology - Wiley Online Library VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair - Waschek - 2013 - British Journal of Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/cc626853-ba46-421e-8ae8-3109ecbe055b/bph12181-fig-0002-m.jpg)
VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair - Waschek - 2013 - British Journal of Pharmacology - Wiley Online Library
![The VIP-VPAC2 neuropeptidergic axis is a cellular pacemaking hub of the suprachiasmatic nucleus circadian circuit | Nature Communications The VIP-VPAC2 neuropeptidergic axis is a cellular pacemaking hub of the suprachiasmatic nucleus circadian circuit | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-17110-x/MediaObjects/41467_2020_17110_Fig1_HTML.png)
The VIP-VPAC2 neuropeptidergic axis is a cellular pacemaking hub of the suprachiasmatic nucleus circadian circuit | Nature Communications
![Frontiers | A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease Frontiers | A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease](https://www.frontiersin.org/files/Articles/482521/fncel-13-00421-HTML/image_m/fncel-13-00421-g004.jpg)
Frontiers | A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease
![Bos Vipr2.2 Rear Shock Sticker Protective Stickers For Mtb Mountain Bike Bicycle Race Cycling Decals - Bicycle Stickers - AliExpress Bos Vipr2.2 Rear Shock Sticker Protective Stickers For Mtb Mountain Bike Bicycle Race Cycling Decals - Bicycle Stickers - AliExpress](https://ae01.alicdn.com/kf/H7dd6c44aee414c7f97e9383f3bf2c918c/BOS-VIPR2-2-rear-shock-sticker-protective-stickers-for-MTB-mountain-bike-bicycle-race-cycling-decals.jpg)
Bos Vipr2.2 Rear Shock Sticker Protective Stickers For Mtb Mountain Bike Bicycle Race Cycling Decals - Bicycle Stickers - AliExpress
![VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair. - Abstract - Europe PMC VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair. - Abstract - Europe PMC](https://europepmc.org/articles/PMC3682700/bin/bph0169-0512-f1.jpg)
VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair. - Abstract - Europe PMC
![Bos Vipr2.2 Rear Shock Sticker Protective Stickers For Mtb Mountain Bike Bicycle Race Cycling Decals - Bicycle Stickers - AliExpress Bos Vipr2.2 Rear Shock Sticker Protective Stickers For Mtb Mountain Bike Bicycle Race Cycling Decals - Bicycle Stickers - AliExpress](https://ae01.alicdn.com/kf/H1c4a64098ecf451da2a1fcbc17e379900/BOS-VIPR2-2-rear-shock-sticker-protective-stickers-for-MTB-mountain-bike-bicycle-race-cycling-decals.jpg_640x640.jpg)
Bos Vipr2.2 Rear Shock Sticker Protective Stickers For Mtb Mountain Bike Bicycle Race Cycling Decals - Bicycle Stickers - AliExpress
![Frontiers | A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease Frontiers | A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease](https://www.frontiersin.org/files/Articles/482521/fncel-13-00421-HTML/image_m/fncel-13-00421-g006.jpg)
Frontiers | A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease
![Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma | Nature Communications Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-022-34242-4/MediaObjects/41467_2022_34242_Fig2_HTML.png)
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma | Nature Communications
![Attenuation of stress-induced gastrointestinal motility disorder by gentiopicroside, from Gentiana macrophylla Pall - ScienceDirect Attenuation of stress-induced gastrointestinal motility disorder by gentiopicroside, from Gentiana macrophylla Pall - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0367326X15001057-fx1.jpg)
Attenuation of stress-induced gastrointestinal motility disorder by gentiopicroside, from Gentiana macrophylla Pall - ScienceDirect
![IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors](https://www.mdpi.com/ijms/ijms-23-08069/article_deploy/html/images/ijms-23-08069-g006.png)
IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors
![Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma | Nature Communications Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-022-34242-4/MediaObjects/41467_2022_34242_Fig5_HTML.png)
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma | Nature Communications
![IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors](https://pub.mdpi-res.com/ijms/ijms-23-08069/article_deploy/html/images/ijms-23-08069-g005.png?1658482743)
IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors
![VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair - Waschek - 2013 - British Journal of Pharmacology - Wiley Online Library VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair - Waschek - 2013 - British Journal of Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/f618bc5f-09be-402f-9a50-82ecb04333f6/bph12181-fig-0001-m.jpg)
VIP and PACAP: neuropeptide modulators of CNS inflammation, injury, and repair - Waschek - 2013 - British Journal of Pharmacology - Wiley Online Library
![IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors](https://www.mdpi.com/ijms/ijms-23-08069/article_deploy/html/images/ijms-23-08069-g001.png)
IJMS | Free Full-Text | Targeting VIP and PACAP Receptor Signaling: New Insights into Designing Drugs for the PACAP Subfamily of Receptors
![Frontiers | A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease Frontiers | A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease](https://www.frontiersin.org/files/Articles/482521/fncel-13-00421-HTML/image_m/fncel-13-00421-g001.jpg)
Frontiers | A Synthetic Agonist to Vasoactive Intestinal Peptide Receptor-2 Induces Regulatory T Cell Neuroprotective Activities in Models of Parkinson's Disease
![Biomedicines | Free Full-Text | Galectins in Cancer and the Microenvironment: Functional Roles, Therapeutic Developments, and Perspectives Biomedicines | Free Full-Text | Galectins in Cancer and the Microenvironment: Functional Roles, Therapeutic Developments, and Perspectives](https://www.mdpi.com/biomedicines/biomedicines-09-01159/article_deploy/html/images/biomedicines-09-01159-g001.png)